AiMeD Backs Haryana’s INR 10,000 Cr Pharma & MedTech Policy, Calls It a Blueprint for India’s Manufacturing Future
Advertisement
The policy establishes a new benchmark by combining capital expenditure (CAPEX) support of up to 30% with operational expenditure (OPEX) assistance of up to 80%
AiMeD has endorsed Haryana's new pharmaceutical and medical devices manufacturing policy, saying the INR 10,000 Cr investment plan, generous incentives, and regulatory reforms could significantly strengthen India's domestic healthcare manufacturing ecosystem.
Haryana has introduced its Pharmaceutical and Medical Devices Manufacturing Policy 2026, which seeks to attract investments exceeding INR 10,000 Cr over the next five years and generate approximately 20,000 employment opportunities across the pharmaceutical and medical device sectors.
AiMeD said the policy establishes a new benchmark by combining capital expenditure (CAPEX) support of up to 30 per cent with operational expenditure (OPEX) assistance of up to 80 per cent.
The incentives are capped at INR 200 Cr for CAPEX and INR 20 Cr for OPEX.
The framework also includes export-linked incentives, patent commercialisation support, research and development encouragement, green manufacturing initiatives, and measures to simplify regulatory approvals.
Welcoming the announcement, Rajiv Nath, Forum Coordinator, AiMeD, said, "We wholeheartedly applaud Haryana's visionary policy. It is the most incentivising framework from any progressive state, combining attractive and highly flexible CAPEX and OPEX incentives with strong support for innovation, sustainability, and exports."
The policy has also been welcomed by Pawan Choudhary, Advisor to the Chief Minister of Haryana for the Foreign Cooperation Department, who highlighted its investor-friendly approach.
“Haryana transforms investor interest into real opportunities. As a trusted partner for long-term economic growth, its landmark policy couples generous CAPEX and OPEX incentives with a transparent single-window system."
"This clarity assures ease of doing business, accelerates overseas investment, and positions Haryana as a preferred global destination for medical device manufacturing," he added.
With its emphasis on financial incentives, regulatory simplification, innovation, and infrastructure development, the Haryana policy is expected to strengthen India's pharmaceutical and medical device manufacturing capabilities while encouraging greater domestic and international investment in the sector.
Stay tuned for more such updates on Digital Health News
